# FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction

Study · id `cardio:ct-nct02943954` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02943954](<https://clinicaltrials.gov/study/NCT02943954>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02943954

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1170 participants.

## Technical summary

Registry record NCT02943954. Randomized; no masking; primary purpose treatment. Start 2016-12 (actual); primary completion 2020-10-24 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1170 participants (planned count; ClinicalTrials.gov record NCT02943954, source copy `cardio:ctgov-nct02943954-2021-11-19`, retrieved 2026-10-26)
- Started: 2016-12 (actual) (ClinicalTrials.gov record NCT02943954, source copy `cardio:ctgov-nct02943954-2021-11-19`, retrieved 2026-10-26)
- Primary completion: 2020-10-24 (actual) (ClinicalTrials.gov record NCT02943954, source copy `cardio:ctgov-nct02943954-2021-11-19`, retrieved 2026-10-26)
- Completion: 2022-01 (anticipated) (ClinicalTrials.gov record NCT02943954, source copy `cardio:ctgov-nct02943954-2021-11-19`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT02943954, source copy `cardio:ctgov-nct02943954-2021-11-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02943954-2021-11-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction
- Acronym: FLOWER-MI
- Condition: Acute ST Segment Elevation Myocardial Infarction
- Condition: Acute Myocardial Infarction
- Condition: Multi Vessel Coronary Artery Disease
- Intervention (Procedure): Angiography guided PCI
- Intervention (Device): Fractional Flow Reserve (FFR)
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER
- Collaborator: Abbott
- Collaborator class: INDUSTRY
- Collaborator: Ministry of Health, France
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)
- Registry lists this organization as a collaborator: Ministry of Health, France (`cardio:org-ministry-of-health-france`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction (`cardio:pubmed-33999545`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial (`cardio:pubmed-34420366`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Three-Year Outcomes With Fractional Flow Reserve-Guided or Angiography-Guided Multivessel Percutaneous Coronary Intervention for Myocardial Infarction (`cardio:pubmed-38785084`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ff890a3ba940091f1b1e15e9cda789f3ddf9fee61c86587e114772a88e0ddce9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
